Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement
Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.
Read more
Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016
Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.